COASTLANDS CAPITAL LP purchased 7.2% of their position (25K shares) of ADIAL PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $65.0K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/1/2026ACC: 0001104659-26-079686
10% Owner
Since Jun 2026
+25K
Net shares
Net buyer
$65.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
25K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+25K
Price / share
$2.60
Trade value
$65K
% of position
7.2%
6/29/2026
348.32K→373.32K
Total
Net shares
+25K
Net value
$65K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/29/2026 | P · Purchase | +25K | $2.60 | $65K | 7.2% | 348.32K | 373.32K |
| Total | +25K | $65K | ||||||
Derivative Transactions0
No derivative transactions reported